Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HilleVax Stock (NASDAQ:HLVX), Quotes and News Summary
HilleVax Stock (NASDAQ: HLVX) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.0 / 67.477K | Mkt Cap571.391M |
| Day Range- - - | 52 Wk Range11.350 - 22.680 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.740 | 0.1600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-05-16 | JP Morgan | Eric Joseph | Maintains | OverweightOverweight | Lowers | 23.00 | 22.00 |
| 2022-05-24 | Guggenheim | Seamus Fernandez | Initiates Coverage On | Buy | Announces | - | 40.00 |
| 2022-05-24 | SVB Leerink | David Risinger | Initiates Coverage On | Outperform | Announces | - | 30.00 |
| 2022-05-24 | JP Morgan | Eric Joseph | Initiates Coverage On | Overweight | Announces | - | 24.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HLVX | HilleVax | 0% | 571.4M |
| CABA | Cabaletta Bio | 0% | 638.1M |
| RNA | Avidity Biosciences | 0% | 523.1M |
| FDMT | 4D Molecular Therapeutics | 0% | 609.8M |
| CNTA | Centessa Pharmaceuticals | 0% | 602.9M |
How do I buy HilleVax (HLVX) stock?
You can purchase shares of HilleVax (NASDAQ: HLVX) through any online brokerage.
Who are HilleVax's (HLVX) competitors?
Other companies in HilleVax’s space includes: Cabaletta Bio (NASDAQ:CABA), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and AnaptysBio (NASDAQ:ANAB).
What is the target price for HilleVax (HLVX) stock?
The latest price target for HilleVax (NASDAQ: HLVX) was reported by JP Morgan on Tuesday, May 16, 2023. The analyst firm set a price target for 22.00 expecting HLVX to rise to within 12 months (a possible 51.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for HilleVax (HLVX)?
The stock price for HilleVax (NASDAQ: HLVX) is $14.57 last updated September 20, 2023 at 8:00 PM UTC.
Does HilleVax (HLVX) pay a dividend?
There is no dividend information for HilleVax.
When is HilleVax (NASDAQ:HLVX) reporting earnings?
HilleVax’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is HilleVax (HLVX) going to split?
There is no upcoming split for HilleVax.
What sector and industry does HilleVax (HLVX) operate in?
HilleVax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.